Paper Details

  1. Home
  2. Paper Details

Dietary habits of psoriatic patients treated with dimethyl fumarate and drug-related side effects: results from an observational study.

Author: BardazziFederico, BorghiAlessandro, CorazzaMonica, DI LerniaVito, GuarneriFabrizio, MontiAlberto, OdoriciGiulia

Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This observational study assessed the dietary habits of patients with moderate-to-severe plaque psoriasis treated with dimethyl fumarate (DMF). The study found that 71.7% of patients reported side effects, including flushing, diarrhea, gastralgia, and nausea. Overweight patients seemed more likely to experience side effects. The study also found a possible correlation between skipping meals and the onset of diarrhea. Further investigation is needed to develop strategies to improve DMF tolerability and retention rate.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Despite its favorable long-term safety profile, side effects during dimethyl fumarate (DMF) treatment for psoriasis are not uncommon and may lead to treatment suspension. The association between side effects, especially gastrointestinal, and dietary habits has not yet been specifically a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.23736/S2784-8671.23.07479-0

データ提供：米国国立医学図書館（NLM）

Dimethyl Fumarate: A Desert Oasis with Potential Side Effects

Dimethyl fumarate (DMF) is a medication used for treating psoriasis, offering a potential oasis of relief from this chronic skin condition. This study investigates the dietary habits of patients with psoriasis who are treated with DMF and explores the relationship between dietary factors and drug-related side effects. The research found a possible link between skipping meals and the occurrence of gastrointestinal side effects. It suggests that dietary interventions may help improve DMF tolerability.

Dimethyl Fumarate: A Balancing Act in the Desert of Psoriasis Treatment

This study examines the relationship between dietary habits and side effects during DMF treatment for psoriasis. The research found that side effects, particularly gastrointestinal symptoms, were commonly reported. Skipping meals appeared to be correlated with the onset of diarrhea, suggesting a possible connection between dietary habits and DMF tolerability. The findings highlight the importance of considering dietary factors when managing DMF treatment.

Dimethyl Fumarate: A Path to Better Tolerability

This research provides valuable insights into the potential role of dietary interventions in improving the tolerability of DMF treatment for psoriasis. Understanding the association between dietary habits and side effects can help healthcare providers develop personalized recommendations for patients, potentially improving treatment outcomes and minimizing adverse events. This research highlights the importance of a holistic approach to managing psoriasis, considering both medication and lifestyle factors.

Dr.Camel's Conclusion

This study reminds us that even in the desert of psoriasis treatment, where there is often a search for relief, there are hidden factors that can influence treatment outcomes. Dietary habits can impact the tolerability of DMF treatment, highlighting the importance of a comprehensive approach that considers both medication and lifestyle factors. This research offers valuable insights into the potential benefits of dietary interventions for improving DMF tolerability and enhancing patient outcomes.

Date :
  1. Date Completed 2023-03-22
  2. Date Revised 2023-03-22
Further Info :

Pubmed ID

36939500

DOI: Digital Object Identifier

10.23736/S2784-8671.23.07479-0

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.